To study the expression level of peptidylarginine deiminase 4 (PADI4) and protein tyrosine phosphatase nonreceptor type 22 (PTPN22) in the synovium of rat model of collagen-induced arthritis

and to explore their possible therapeutic role in rheumatoid arthritis. Thirty-two female Wistar rats weighing 100±20 g were randomly assigned into 3-week collagen-induced arthritis (CIA) model group (=8)

4-week CIA model group (=8)

6-week CIA model group (=8)

and the control group (=8). The body weight changes of each group were recorded. The expression levels of PADI4 and PTPN22 were detected and compared by the methods of immunohistochemical staining and Western blot. Arthritis of rat began to form 14 days after sensitization and the joint swelling reached peak at 28 days. The weights of the rats slowly grew both in CIA model groups and the control group. Immunohistochemical staining results showed that the positive expression of PADI4 and PTPN22 was mainly located in cartilage peripheral mononuclear cells

the cytoplasm of infiltrated cells

and bone marrow cavity. There were significant differences in the optical density of PADI4 and PTPN22 among CIA model groups and the control group (PADI4

0.2898±0.012

0.2982±0.022

0.2974±0.031

0.2530±0.013 in 3-week CIA model

4-week CIA model

6-week CIA model and control groups; PTPN22

0.2723±0.004

0.2781±0.010

0.2767±0.008

0.2422±0.019; all <0.05). The expression bands of PADI4 were observed in Western blot 3 weeks after initial immunization

the thickest in the 4th week

and decreased in the 6th week. The expression bands of PTPN2 were observed at all the time points

with no obvious time-dependent trend. PADI4 and PTPN22 are obviously correlated with CIA in rat model. PADI4 is expressed at early stage of the disease

while the expression of PTPN22 sustains throughout the course.